logo

Quick Facts

Share

PrimeEnergy Resources Corporation (PNRG) Friday reported first-quarter net income of $11.1 million or $4.07 per shared, compared to net loss of $1.46 million or $0.73 per share last year. Revenues for the quarter were $26.2 million, a surge from $13.0 million last year. The company's barrel of...

Novartis (NVS) said Friday that the Committee for Medicinal Products for Human Use or CHMP of the European Medicines Agency or EMA has adopted a positive opinion for Cosentyx (secukinumab), used alone or in combination with methotrexate, in the juvenile idiopathic arthritis categories of enthesitis-related...

Lear Corp. (LEA) agreed to acquire I.G. Bauerhin (IGB), a privately held supplier of automotive seat heating, ventilation, active cooling, steering wheel heating, seat sensors, and electronic control modules, for 140 million euros, on a cash- and debt-free basis. The transaction is expected to close...

Biopharmaceutical company Cortexyme, Inc. (CRTX) announced Friday the completion of its acquisition of privately-held biotech company Novosteo, which targets therapeutics to treat rare skeletal diseases, bone cancer and injury. Novosteo stockholders now own approximately 15.5% of the combined company. With...

Immix Biopharma Inc. (IMMX) announced positive interim study data showing that after one cycle of treatment, ImmixBio's lead candidate IMX-110 produced 75% survival vs. 0% survival for Trabectedin in a connective tissue cancer Soft Tissue Sarcoma or STS mice study. Trabectedin is sold as YONDELIS...

Biopharmaceutical company AbbVie Inc. (ABBV) announced Friday that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for ABBV-951 (foscarbidopa/foslevodopa) for the treatment of motor fluctuations in patients with advanced Parkinson's disease (PD). The submission...

Nissan Motor Co., Ltd. (NSANF.PK, NSANY.PK) on Friday unveiled the all-new Sakura electric minivehicle in Japan, while Mitsubishi Motors Corp. (MMTOF.PK) announced the launch of an easy-to-use, all-electric microcar eK X EV in Japan, with both offering a range of 180 kms. The Sakura EV is equipped...

The European Medicines Agency's or EMA Committee for Medicinal Products for Human Use or CHMP has issued a positive opinion for Olumiant (baricitinib) for the treatment of adults with severe alopecia areata (AA), Eli Lilly and Co. (LLY) and Incyte (INCY) said in a statement on Friday. The European...

PTC Therapeutics Inc. (PTCT) said that Upstaza received a positive opinion from the Committee for Medicinal Products for Human Use or CHMP of the European Medicines Agency or EMA. Once ratified by the European Commission, Upstaza will be the first approved disease-modifying treatment for aromatic...

Match Group, Inc. (MTCH) announced Friday it has withdrawn its request for a temporary restraining order against Google, after Google made various concessions that Match Group demanded to benefit consumers. Those include guaranteeing that Match Group apps will still be allowed to offer users choice...

While providing an update on its business, 2023-2025 business growth strategy and financial goals ahead of its 2022 Analyst & Investor Day in New York City later on Friday, medical devices maker Teleflex, Inc. (TFX) reaffirmed its earnings and revenue growth guidance for full-year 2022. For fiscal...

Specialty athletic retailer Foot Locker, Inc. (FL) reported Friday that its first-quarter net income attributable to the company declined to $133 million or $1.37 per share from prior year's $202 million or $1.93 per share. Adjusted net income was $155 million, compared to $205 million last year....

Dutch consumer internet group Prosus N.V. (PROSY, PROSF), majority-owned by Naspers, Friday said it has now decided to exit the Russian business, and to sell its shareholding in Russian classifieds business Avito. On March 25, the company had announced the separation of Avito from its OLX Group. The...

LumiraDx Ltd. (LMDX), a diagnostics company, announced Friday that its rapid COVID-19 antigen assay, LumiraDx SARS-CoV-2 Ag Test has successfully received the Emergency Use Listing or EUL by the World Health Organization in their latest response effort to combat COVID-19. The decision by the WHO to...

Italian pharmaceutical company Menarini Group and Radius Health, Inc. (RDUS) announced Friday positive data from the pivotal phase 3 EMERALD clinical trial (NCT03778931) evaluating elacestrant as a monotherapy vs. standard of care for the treatment of ER+/HER2- advanced or metastatic breast cancer. The...

Follow RTT